omnoMed is a global medical device company, founded in 2004 and listed on the Australian Stock Exchange, operating in 28 countries. With headquarters in Sydney, Australia, and offices in Europe and the United States, SomnoMed specializes in developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA). Our oral appliances have successfully treated patients worldwide with mild and moderate OSA, providing comfortable and effective solutions.
SomnoMed is a leader in developing OSA devices, with each appliance custom-made using state-of-the-art technology...